E. Gudemez et al., Effect of anti-ICAM-1 antibodies on macromolecular leakage and leukocyte activation: A study of hindlimb allografts in the rat, PLAS R SURG, 104(1), 1999, pp. 161-170
We investigated the ability of anti-ICAM-1 monoclonal antibodies to reduce
endothelial cell damage by assessing microvascular permeability and microci
rculatory function during the acute phase of allograft rejection. The compo
site rat hindlimb-cremaster muscle transplantation model was employed in th
ree experimental groups of 18 animals each. Isograft control transplantatio
ns were performed between genetically identical Lewis (LEW, RT11) rats. All
ograft transplantations were performed across a major histocompatibility ba
rrier between Lewis-Brown-Norway (LBN, RT-11+n), and Lewis (LEM, RT11) rats
. In addition, a third group of animals receiving allografts was treated wi
th 1 mg/kg/day of anti-ICAM-1 monoclonal antibody. After 24 hours, 72 hours
, and 7 days, we measured microvascular permeability, leukocyte activation,
functional capillary perfusion, red blood cell velocity, vessel diameters,
and endothelial edema index in six animals per each follow-up period. Endo
thelial cell damage was assessed by measuring graft permeability to fluores
cein isothiocyanate-labeled albumin (0.2 ml/100 g body weight) with compute
r-aided image analysis. Mean microvascular permeability was lower in the tr
eated allograft group than in untreated controls at all follow-up times (p
< 0.001). In addition, anti-ICAM I-l treatment significantly reduced the ac
tivation of sticking leukocytes at 24 and 72 hours (p < 0.001) and the acti
vation of transmigrating leukocytes at 72 hours and 7 days (p < 0.05). The
allografts presented a characteristic microcirculatory pattern of acute rej
ection as early as 24 hours after transplantation. The dysfunction of the e
ndothelial cell barrier at all time points was indicated by significant inc
reases in the degree of allograft macromolecular permeability and in the nu
mber of activated sticking and transmigrating leukocytes. Treatment with an
ti-ICAM-1 antibodies significantly reduced the surge of leukocytes in the a
llograft transplants and protected the endothelial barrier from the acute e
ffects of transplantation trauma.